July 6, 20234:48 PM ET Heard on Morning Edition Jon Hamilton The Food and Drug Administration has fully approved Leqembi, the first drug shown to slow down Alzheimer’s disease. Andrew Harnik/AP The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer’s disease. The action means that Leqembi, whose…
Read More Health Tips :
NPR: Alzheimer's drug gets full FDA approval. Medicare coverage will likely follow NPR: CDC recommends 2nd COVID boosters for some older and immunocompromised people FDA Grants Historic Approval to Alzheimer’s drug Designed to Slow Cognitive Decline Texas Assisted Living Facilities Receive COVID-19 Vaccine
